Lenvatinib Mesylate Intermediate CAS 205448-65-3 Tsarkake> 98.0% (HPLC) Factory

Takaitaccen Bayani:

Sunan Kemikal: Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate

Saukewa: 205448-65-3

Tsafta:> 98.0% (HPLC)

Bayyanar: Kashe-Fara zuwa Foda mai launin rawaya

Matsakaicin Lenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate
Makamantu 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Matsakaicin Lenvatinib 3
Lambar CAS 205448-65-3
Lambar CAT RF-PI1973
Matsayin Hannun jari A cikin Hannun jari, Ƙarfin Samar da 50 MT/Shekara
Tsarin kwayoyin halitta Saukewa: C12H11NO4
Nauyin Kwayoyin Halitta 233.22
Wurin Tafasa 421.0 ± 45.0 ℃
Yawan yawa 1.267± 0.060 g/cm3
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Kashe-Fara zuwa Foda mai launin rawaya
Tsarkake / Hanyar Bincike 98.0% (HPLC)
Asara akan bushewa <1.00%
Ragowa akan Ignition <0.50%
Jimlar ƙazanta <2.00%
H-NMR Yayi daidai da Tsarin
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Magunguna

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

1

FAQ:

Aikace-aikace:

Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) matsakanci ne na Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib, wanda ake sayar da shi a ƙarƙashin sunan alamar Lenvima da sauransu, magani ne na maganin ciwon daji don maganin wasu nau'in ciwon daji na thyroid da sauran ciwon daji.Eisai Co. ne ya haɓaka shi kuma yana aiki azaman mai hana kinase mai yawa akan VEGFR1, VEGFR2 da VEGFR3 kinases.Lenvatinib an yarda da shi (tun 2015) don maganin bambance-bambancen ciwon daji na thyroid wanda shine ko dai a cikin gida ko kuma metastatic, ci gaba, kuma bai amsa magani tare da iodine radioactive (radioiodine).A cikin watan Mayu 2016, Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da shi (a hade tare da everolimus) don maganin ci-gaban ciwon daji na renal cell bayan daya kafin maganin angiogenic.An kuma yarda da maganin a cikin Amurka da Tarayyar Turai don ciwon hanta wanda ba za a iya cirewa ta hanyar tiyata a cikin marasa lafiya waɗanda ba su sami maganin ciwon daji ta baki ko allura ba.

Ku rubuta sakonku anan ku aiko mana